Vincerx Pharma, Inc.
VINC
$0.049
-$0.006-10.91%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.99M | 10.09M | 16.32M | 5.11M | 12.78M |
| Total Receivables | 1.04M | 1.06M | 1.02M | 1.03M | 1.04M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 89.00K | 283.00K | 530.00K | 700.00K | 51.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 293.00K | 316.00K | 416.00K | 842.00K | 856.00K |
| Total Current Assets | 6.41M | 11.75M | 18.28M | 7.68M | 14.73M |
|
|
|||||
| Total Current Assets | 6.41M | 11.75M | 18.28M | 7.68M | 14.73M |
| Net Property, Plant & Equipment | -- | 1.52M | 1.79M | 2.06M | 2.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.60M | 1.68M | 1.45M | 1.35M | 1.16M |
| Total Assets | 8.01M | 14.95M | 21.53M | 11.08M | 18.22M |
|
|
|||||
| Total Accounts Payable | 2.03M | 1.96M | 1.54M | 2.31M | 2.50M |
| Total Accrued Expenses | 3.24M | 1.72M | 2.43M | 1.73M | 1.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 1.27M | 1.24M | 1.20M | 1.16M |
| Total Finance Division Other Current Liabilities | 8.00K | 463.00K | 132.00K | 5.40M | 191.00K |
| Total Other Current Liabilities | 8.00K | 463.00K | 132.00K | 5.40M | 191.00K |
| Total Current Liabilities | 5.28M | 5.42M | 5.33M | 10.63M | 5.61M |
|
|
|||||
| Total Current Liabilities | 5.28M | 5.42M | 5.33M | 10.63M | 5.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 365.00K | 697.00K | 1.02M | 1.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 50.00K | 50.00K | 50.00K | 50.00K |
| Total Liabilities | 5.28M | 5.84M | 6.08M | 11.71M | 7.00M |
|
|
|||||
| Common Stock & APIC | 191.79M | 190.20M | 188.77M | 170.86M | 170.33M |
| Retained Earnings | -189.19M | -181.19M | -173.35M | -171.54M | -159.11M |
| Treasury Stock & Other | 119.00K | 104.00K | 24.00K | 60.00K | 8.00K |
| Total Common Equity | 2.72M | 9.11M | 15.45M | -622.00K | 11.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.72M | 9.11M | 15.45M | -622.00K | 11.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.72M | 9.11M | 15.45M | -622.00K | 11.22M |
|
|
|||||